Disease/Infection News

RSS

Public health officials offer scant details on U.S. coronavirus patients

Disclosure this week of a sixth case in the United States of a new viral infection emerging from China — and the first confirmed case of the virus passing from person to person in this country — is fueling public concerns about how easily the deadly virus can spread.

3 Feb 2020

Coronavirus taking an economic toll on China

The novel coronavirus or 2019-nCoV outbreak has negatively impacted the economy of China and other countries worldwide. With China’s isolation from other countries and travel bans imposed, the economic toll is rippling across the world.

3 Feb 2020

China reports H5N1 bird flu in Hunan amid coronavirus crisis

China has reported an outbreak of the H5N1 bird flu in Hunan, which borders the province of Hubei, the epicenter of the novel coronavirus outbreak.

3 Feb 2020

New, highly potent HIV antibody restricts development of viral resistance

Antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require lifelong daily application and can be associated with side effects.

31 Jan 2020

GENOMICA is developing new Wuhan coronavirus diagnostic kit

GENOMICA, a wholly owned company of PharmaMar Group, is developing a kit to reliably detect and identify the new virus known as "Wuhan pneumonia" (coronavirus 2019-nCoV).

31 Jan 2020

A new study reveals the secrets of mucus production that could be applied to cancer biology

The cells that produce mucus are known to be involved in serious health conditions such as asthma, chronic obstructive pulmonary disease, and even cancer.

31 Jan 2020

First exposure to influenza virus dictates our lifelong ability to fight flu

Were you born in an H1N1 year or an H3N2 year? The first type of influenza virus we are exposed to in early childhood dictates our ability to fight the flu for the rest of our lives, according to a new study from a team of infectious disease researchers at McMaster University and Université de Montréal.

30 Jan 2020

Going vegan lowers risk of urinary tract infection

Urinary tract infections (UTIs) are usually caused by bacteria, such as Escherichia coli, which is normally found in the gut but enters the urinary tract through the urethra. UTIs, when left untreated, can reach and affect the kidneys. It is one of the most common microbial infections across the globe, with a worldwide prevalence of 10 in 1,000 people.

30 Jan 2020

Coronavirus outbreak now a global health emergency says WHO

The Wuhan coronavirus or 2019-nCoV outbreak continues to spread in mainland China and in more than a dozen countries. In the last 24 hours, 42 had succumbed to the infection, making the death toll hit 213, with 9,692 confirmed cases, prompting the World Health Organization (WHO) to declare the coronavirus outbreak a global health emergency.

30 Jan 2020

State-purchased insurance plans improve HIV outcomes, save healthcare costs

Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests.

30 Jan 2020

Research uncovers how HIV develops resistance to key drugs

The mechanism behind how HIV can develop resistance to a widely-prescribed group of drugs has been uncovered by new research from the Crick and Dana-Farber Cancer Institute, with the findings opening the door to the development of more effective treatments.

30 Jan 2020

Masks signal cultural disconnect as L.A.’s Chinese community braces for coronavirus

Several staff members of a small community health clinic in L.A.'s historic Chinatown spoke on the phone with patients Tuesday while wearing face masks that muffled their voices.

30 Jan 2020

Advances in tuberculosis research yield immune responses

A new study published in January 2020 in the journal Science Translational Medicine depicts for the first time ever a beautifully detailed map of the way three different species reacts to tuberculosis, based on their genetic and immune differences.

30 Jan 2020

Do masks protect from Coronavirus?

As the new Wuhan coronavirus, designated 2019-nCoV, spreads around the world, people are increasingly turning to face masks for protection. The question is, are masks really needed?

30 Jan 2020

Scientists reveal clinical features of Wuhan coronavirus patients

The Wuhan coronavirus, or the 2019-nCoV, which originated in Wuhan City in Hubei province infected more than 7,700 people with the death toll topping more than 170. China reports 38 deaths in just 24 hours, making the outbreak one of the deadliest ones the country has faced.

30 Jan 2020

Wuhan coronavirus is genetically different from human SARS, MERS-CoV, study found

The Wuhan coronavirus or the 2019-nCoV or novel coronavirus is a new human-infecting coronavirus genetically different from human SARS (Severe Acute Respiratory Syndrome), and MERS-CoV (Middle East Respiratory Syndrome), a team of scientists has found.

30 Jan 2020

Rapid weather variability could increase risk of a flu epidemic

New research from a team of Florida State University scientists shows that rapid weather variability as a result of climate change could increase the risk of a flu epidemic in some highly populated regions in the late 21st century.

30 Jan 2020

Study maps immune responses to tuberculosis across 3 species

Tuberculosis is one of the world's most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization estimates that one-quarter of the world's population -- some 2 billion people, mostly in developing countries -- are infected with the bacteria that causes TB.

30 Jan 2020

CSIRO begins key research on novel coronavirus

CSIRO, Australia’s national science agency, has commenced key research in the rapid global response to the novel coronavirus outbreak.

From CSIRO 30 Jan 2020

ERA4TB to transform the development of new therapies for tuberculosis

With a team of more than thirty public and private organisations and a budget over 200 million euro, ERA4TB aims to radically transform the way in which new therapies are developed for the treatment of tuberculosis.

30 Jan 2020